MNKD vs PATH · rev $285.5M vs P/E 19, rev $1.61B
MannKind Corp (MNKD) versus Uipath Inc (PATH) — a side-by-side from cached financials, not a winner call.
MannKind Corp (MNKD) is a biotechnology company listed on US.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
Latest reported MNKD revenue for 2024-12-31 was $285.5M. Net income was $27.6M. Revenue was up 43.5% from 2023-12-31 to 2024-12-31. MNKD currently screens at market cap $1.28B.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
MNKD currently screens at market cap $1.28B. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Not investment advice. Open the MNKD and PATH stock pages for the full models.
Not investment advice.